Core Viewpoint - RadNet, Inc. is hosting a conference call on March 5, 2026, to discuss the acquisition of Gleamer SAS and its Digital Health strategy, providing an opportunity for investors to engage with executive management [1]. Company Overview - RadNet, Inc. is a leading provider of diagnostic imaging services in the U.S., operating a network of outpatient imaging centers across multiple states including Arizona, California, and Texas [3]. - The company employs over 11,000 team members, including radiologists and technologists, and offers radiology information technology and AI solutions under the DeepHealth brand [3]. DeepHealth Segment - DeepHealth, a subsidiary of RadNet, focuses on AI-powered health informatics aimed at enhancing imaging care [4]. - The DeepHealth OS is a cloud-first operating system that integrates data across clinical and operational workflows, improving disease detection and clinical outcomes [5]. Gleamer Acquisition - Gleamer, founded in 2017, provides AI solutions for medical imaging, addressing the rising demand due to an aging population and chronic diseases [6]. - The company has analyzed over 30 million exams across 2,250 locations in 44 countries, with its solutions recognized in over 60 peer-reviewed publications [6].

RadNet FY Conference Summary Company Overview - **Company**: RadNet (NasdaqGM:RDNT) - **Industry**: Medical Imaging and Digital Health Key Points Financial Performance and Guidance - **2026 Revenue Growth**: Anticipated growth of 16% to 18% in imaging centers and over 50% in digital health [6][12] - **EBITDA Growth**: Expected to grow faster than revenue on the imaging center side, indicating margin expansion opportunities [6][12] - **Acquisition Impact**: Two imaging center acquisitions announced, contributing mid to high single digits to EBITDA [13][14] Market Trends and Growth Drivers - **Advanced Imaging Growth**: Historic growth in advanced imaging modalities (MRI, CT, PET CT) with double-digit growth in PET CT [12][39] - **Same Center Procedure Volume**: Mid to high single-digit growth in advanced imaging, with PET CT expected to show double-digit growth [12][26] - **Technological Advancements**: Improvements in imaging technology and equipment are driving demand for advanced imaging [39][40] Operational Challenges - **Labor Costs**: Built-in guidance for a 4% increase in same center labor costs, estimated around $30 million [21][22] - **Weather Impact**: Anticipated $7 million to $9 million revenue impact from bad weather in the Northeast [89][90] Digital Health and AI Integration - **DeepHealth Platform**: Integration of workflow solutions and clinical AI to enhance productivity and accuracy for radiologists [50][56] - **Gleamer Acquisition**: AI-assisted reads for X-ray expected to improve efficiency and reduce costs in high-volume, low-reimbursement X-ray procedures [62][74] Future Opportunities - **New Center Openings**: Plans to build 11 to 13 new de novo centers in 2026, contributing to revenue growth [19][20] - **FDA Approvals**: Four FDA approvals expected in the coming quarters, including AI products for lung and prostate imaging [130][134] Competitive Landscape - **Market Position**: RadNet aims to lead the industry in integrating AI solutions into imaging workflows, addressing labor shortages and operational inefficiencies [60][61] - **Peer Comparison**: Discussion on differing strategies with competitors regarding technology adoption and investment in systems [56][57] Miscellaneous Insights - **Call Center Costs**: $60 million spent on human call centers, with potential for 10% savings through automation [83][84] - **Acquisition Strategy**: Recent acquisition of Radiology Regional for $65 million, with expectations for accelerated margin normalization [108][109] This summary encapsulates the key insights from RadNet's FY conference, highlighting the company's growth strategies, operational challenges, and future opportunities in the medical imaging and digital health sectors.

Core Insights - RadNet, Inc. has acquired Gleamer SAS, a leading radiology AI company, to enhance its DeepHealth subsidiary, making it the largest provider of radiology clinical AI solutions globally [1][2]. Company Overview - RadNet is a prominent provider of outpatient diagnostic imaging services in the U.S., operating a network of imaging centers across multiple states [11]. - DeepHealth, a wholly owned subsidiary of RadNet, focuses on AI-powered health informatics to improve imaging care [12]. Acquisition Details - The acquisition is an all-cash transaction valued at up to €230 million, reflecting Gleamer's strong recurring revenue growth and high customer retention rates [7]. - Gleamer has achieved an Annual Recurring Revenue (ARR) compound annual growth rate exceeding 90% from 2022 to 2025, with expectations to reach approximately $30 million ARR in 2026 [2]. Strategic Impact - The integration of Gleamer's AI solutions is expected to enhance DeepHealth's portfolio, providing comprehensive clinical AI solutions across various imaging modalities, including MR, CT, X-ray, Mammography, and Ultrasound [4][20]. - The acquisition aims to improve operational efficiency and patient care by automating workflows and increasing the accuracy of radiological interpretations [6][4]. Market Position - With the acquisition, DeepHealth and Gleamer together anticipate achieving an ARR approaching or exceeding $140 million by the end of 2026, solidifying their leadership in the clinical radiology AI market [20]. - Gleamer serves over 700 customer contracts in 44 countries, showcasing its extensive reach and impact in the radiology AI sector [2]. Future Outlook - The deployment of Gleamer's solutions is expected to drive productivity gains, particularly in X-ray imaging, which constitutes nearly 25% of RadNet's imaging volume [6]. - The combined strengths of RadNet and Gleamer are positioned to redefine imaging delivery through intelligence and automation, enhancing access and efficiency in healthcare [5].

Core Insights - DeepHealth, Inc. has received CE marking for its TechLive™ solution, enabling its commercialization in Europe as the first remote imaging and radiology management solution that oversees MR, CT, PET/CT, and ultrasound [1][3] - TechLive aims to address the rising demand for complex imaging in Europe, where workforce shortages are critical, by allowing certified experts to operate across multiple modalities and locations [2][3] Company Overview - DeepHealth is a wholly owned subsidiary of RadNet, Inc. and focuses on AI-powered health informatics to enhance imaging care [5] - RadNet is a leading provider of diagnostic imaging services in the U.S., operating a network of outpatient imaging centers across several states [6] Product Features and Benefits - TechLive is a multimodality, vendor-agnostic solution that consolidates various imaging controls and patient monitoring into a single interface, improving operational efficiency [2][3] - The solution has connected over 400 scanners within RadNet, resulting in a 42% reduction in MR room closure hours and a 27% increase in access to complex procedures [3][13][14] Market Position and Strategy - The listing of TechLive in AWS Marketplace aims to simplify procurement and deployment, leveraging AWS's infrastructure to enhance implementation speed and align with IT strategies [3] - DeepHealth plans to showcase TechLive at the 2026 European Congress of Radiology, highlighting its integrated portfolio of AI-powered solutions [4]

Core Insights - RadNet, Inc. has announced the acquisition of CIMAR UK to enhance its cloud-native healthcare image management solutions and integrate them with DeepHealth's AI-powered informatics [1][10][11] Group 1: Acquisition Details - The acquisition aims to advance connected imaging-based care by combining CIMAR's extensive image management infrastructure with DeepHealth's AI capabilities [2][3] - CIMAR's solutions are already deployed across over 50% of National Health Service Trusts and 80% of UK private hospital groups, indicating a strong market presence [2] - The integration is expected to create a richer solution for efficient and accessible imaging-based care across the UK [3] Group 2: Impact on Healthcare - The acquisition is positioned as a pivotal moment for CIMAR, allowing for a broader impact and improved access to intelligent imaging solutions [4] - DeepHealth's existing partnership with CIMAR supports NHS England's Lung Cancer Screening Program, which has shown early success in detecting lung cancers at more treatable stages [4][5] - The program has improved early detection rates from 29% historically to 76% for lung cancers detected through the screening initiative [4] Group 3: Future Aspirations - DeepHealth aims to scale digitally enabled care models across the UK and Europe, expanding the reach of connected healthcare models [5] - The combined capabilities of CIMAR and DeepHealth are expected to empower healthcare providers with advanced tools for medical imaging innovation [4][5]

Core Viewpoint - RadNet, Inc. has acquired Alpha RT, enhancing its remote imaging portfolio and addressing the growing demand for radiology services amid a shortage of imaging technologists [1][2] Company Overview - RadNet is a leading provider of diagnostic imaging services in the US, operating 405 outpatient imaging centers across several states including California, New York, and Texas [3] - The company employs approximately 11,000 team members, including radiologists and technologists, and offers a range of services including radiology information technology and AI solutions under the DeepHealth brand [3] Acquisition Details - The acquisition of Alpha RT integrates its staffing services and training programs with RadNet's existing TechLive™ remote scanning technology, creating a comprehensive remote-imaging portfolio [1][2] - This strategic move aims to empower imaging centers to manage increasing procedural volumes while maintaining high patient care standards [2] Technology and Services - DeepHealth's TechLive™ technology allows expert technologists to remotely perform or supervise various imaging scans, achieving a 0.06% recall rate and a 42% reduction in MRI room closures [5][11] - Alpha RT provides AI-powered safety monitoring, on-demand staffing services, specialized training programs, and intelligent resource optimization to enhance operational efficiency [5] Market Context - The acquisition responds to rising patient demand for radiology services and a concurrent shortage of imaging technologists, presenting significant challenges for imaging providers [2] - DeepHealth's solutions are utilized by thousands of radiologists globally, aiming to improve disease detection and operational efficiency in healthcare [6]

Summary of RadNet Conference Call Company Overview - **Company**: RadNet - **Industry**: Healthcare Services, specifically diagnostic imaging - **Position**: Largest operator of independent freestanding imaging facilities in the U.S., with significant operations on the East and West Coasts [1][3] Core Business Performance - **Growth Rate**: RadNet has achieved a 9.1% compound annual growth rate in revenue since 2007, with recent acceleration in growth due to increased patient volume in outpatient centers [3][4] - **Same-Center Procedure Volume**: Historically in the 2% to 4% range, now routinely in the mid-single digits, particularly for advanced imaging, with over 15% growth in same-center PET/CT procedures [3][4] - **Margin Enhancement**: Driven by operational improvements and a new digital health platform, leading to increased efficiency and productivity [4][6] Business Segments 1. **Imaging Clinics**: Core business with significant growth driven by demographic changes and a shift towards outpatient care [12][14] 2. **Clinical AI**: Development of AI solutions to enhance operational efficiency and accuracy in imaging [6][9] 3. **Digital Health Platform**: DeepHealth OS, a cloud-based operating platform that automates various processes, improving efficiency across the business [25][27] Market Trends - **Demand for Diagnostic Imaging**: Growing demand driven by an aging population and advancements in imaging technology [12][13] - **Shift to Freestanding Centers**: Increasing market share for outpatient imaging centers as patients and payers prefer lower-cost alternatives to hospital imaging [14][21] - **Joint Ventures with Hospitals**: RadNet is partnering with hospitals to create outpatient centers, allowing hospitals to benefit from the shift in imaging services [21][23] Technology and Innovation - **DeepHealth OS**: Expected to drive significant efficiencies in operations, including automated scheduling and insurance verification [25][27] - **CMODE Acquisition**: An ultrasound AI company that automates thyroid ultrasound processes, expected to reduce exam times and increase capacity [33][35] - **Advanced Imaging Growth**: Notable growth in PET/CT procedures, with expectations for new FDA-approved radiopharmaceuticals to further drive demand [39][40] Financial Outlook - **Capital Expenditure**: Anticipated spending of $150 million to $160 million in CapEx to support growth and expansion [43][44] - **Cash Position**: Over $800 million in cash on the balance sheet, providing financial flexibility for investments [43] Investor Insights - **Optimism for the Future**: The company is well-positioned for growth in the diagnostic imaging sector, with a strong capital structure and management team [50] - **Transformation in Imaging**: Anticipated industry transformation over the next decade with the adoption of digital solutions [50] Key Takeaways - RadNet is experiencing robust growth in the diagnostic imaging sector, driven by demographic trends and technological advancements - The company is strategically positioned to capitalize on the shift towards outpatient care and the integration of digital health solutions - Continued investment in technology and partnerships with hospitals will enhance operational efficiency and expand market reach [3][4][12][14][50]

Financial Data and Key Metrics Changes - Total company revenue increased by 8.4% to a quarterly record of $498,200,000 compared to the same quarter last year [8][24] - Adjusted EBITDA rose by 12.3% to a record $81,200,000, up from $72,300,000 in the previous year [13][24] - Adjusted EBITDA margin improved to 16.3%, compared to 15.7% in the same quarter last year, reflecting a margin expansion of almost 60 basis points [13][24] Business Line Data and Key Metrics Changes - Digital health segment revenue increased by 30.9% to a quarterly record of $20,700,000 [8][24] - Advanced imaging procedures grew by 9% in aggregate and 6.6% on a same-center basis compared to last year's second quarter [22] - PETCT procedures saw a significant increase of 22.4% on an aggregate basis and 16.2% on a same-center basis [11][22] Market Data and Key Metrics Changes - The company reported a cash balance of $833,000,000 and a net debt to adjusted EBITDA ratio of 0.96 as of June 30, 2025 [18][26] - Days sales outstanding (DSOs) improved to 32.4 days, slightly lower than the previous year [26] Company Strategy and Development Direction - The company is focusing on expanding advanced imaging procedures and enhancing operational efficiency through technology such as TechLive and C Mode [12][35] - There is a strong emphasis on integrating AI solutions to improve diagnostic accuracy and operational workflows [33][35] - The company plans to open nine additional facilities by the end of the year and has 11 more in development for 2026, indicating a commitment to expanding capacity [23][47] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the recovery from disruptions caused by wildfires and severe weather, highlighting a return to growth [8][22] - The anticipated increase in Medicare reimbursement rates is expected to provide a revenue uplift of approximately $4 to $5 million in 2026 [30][31] - The company is confident in its ability to invest its cash balance in opportunities that align with strategic objectives [18][27] Other Important Information - The acquisition of iCAD and C Mode Technology is expected to enhance the company's capabilities in AI-powered diagnostic solutions [15][16] - The company is actively evaluating a pipeline of acquisition opportunities in both core imaging services and digital health [18][67] Q&A Session Summary Question: Can you discuss the anticipated capacity increase from new technologies and facilities? - Management highlighted a 40% reduction in MRI room closures due to TechLive, which significantly increases capacity [40][41] - The company expects to add 22 additional centers, representing a 5% increase in capacity [47][48] Question: What is the initial feedback from the iCAD customer base regarding cross-selling opportunities? - Management indicated it is early in the integration process but is pleased with the quality of the sales and marketing teams [49] Question: How does the company view the impact of EBCD reimbursement announcements on payer conversations? - Management noted that the endorsement from a capitated group for EBCD is expected to influence other payers positively [51] Question: What are the anticipated margins from the implementation of new technologies? - Management expects substantial flow-through margins as more scans are performed in existing facilities without significant additional costs [65] Question: How is the company planning to allocate capital for M&A and de novo facilities? - The company plans to focus on traditional imaging center acquisitions while also evaluating digital health opportunities [67]

Core Viewpoint - RadNet, Inc. has completed the acquisition of iCAD, Inc., enhancing its capabilities in AI-powered breast health solutions and advancing its mission in diagnostic imaging and digital health [1][2][6] Company Overview - RadNet is a leading provider of diagnostic imaging services in the U.S., operating 401 outpatient imaging centers and employing over 11,000 staff [4] - DeepHealth, a subsidiary of RadNet, focuses on AI-powered health informatics to improve clinical outcomes in various health areas, including breast health [5] Acquisition Details - The acquisition integrates iCAD's commercial, technology, and regulatory capabilities into DeepHealth, aiming to improve breast cancer detection and screening programs [2][6] - iCAD's AI portfolio is deployed in over 50 countries and includes solutions for breast cancer detection, risk evaluation, and workflow efficiency [2][3] Market Impact - The acquisition allows DeepHealth to access over 1,500 healthcare provider locations globally, enabling the delivery of more than 10 million mammograms annually [3] - This strategic move is expected to accelerate AI adoption and enhance screening compliance, particularly in underserved communities [3][6]

RadNet Overview - RadNet is the largest national owner and operator of fixed-site diagnostic imaging centers, with 399 locations[6] - The company's estimated revenue for 2024 is $1.8 billion, and the estimated EBITDA is $280 million[7] - RadNet has over 10,000 employees across 8 states[7] - Approximately 8% of RadNet's revenue comes from capitation customers, managing over 1.8 million lives[8] - Digital Health revenues are expected to exceed $60 million in 2024, with the AI portion expected to reach $20 million in revenue and profitability by year-end[11] Diagnostic Imaging Market - The national imaging market is estimated to be over $100 billion[22] - RadNet operates in states with approximately 25% of the US population[37] Financial Performance and Guidance - RadNet's Q3 2024 adjusted EBITDA increased by 27.2% compared to Q3 2023[58] - AI Revenue within the Digital Health reporting segment increased 175.8% to $5.1 million from last year's third quarter[59] - The company's net debt as of September 30, 2024, was $261 million[68]